Get 20% lifetime commission for referring investors to digrin.com
here.
Stereotaxis, Inc. ( STXS) - Key Metrics
STXS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.08 | -$0.04 | -$0.04 | -$0.04 |
| 2026Q1 | $0.06 | -$0.06 | -$0.03 | -$0.04 |
| 2025Q4 | $0.09 | -$0.06 | -$0.04 | -$0.04 |
| 2025Q3 | $0.08 | -$0.07 | -$0.05 | -$0.05 |
| 2025Q2 | $0.10 | -$0.04 | -$0.04 | -$0.04 |
STXS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.60 |
| 2026Q1 | 0% | -7.37 |
| 2025Q4 | 0% | -9.43 |
| 2025Q3 | 0% | -10.55 |
| 2025Q2 | 0% | -11.25 |
STXS
Price: $1.01
52 week price:
Earnings Per Share: -0.24 USD
Exchange: ASE
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 50343
Ebitda: -5.0 millionMarket Capitalization: 115.6 million